v3.26.1
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)
Total
Series A, Preferred Stock
Series C, Preferred Stock
Series D, Preferred Stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Series A-1 Preferred Stocks
Series D 1 Preferred Stock
Equity Issuable
Equity Consideration Payable
Series E Preferred Stock
Series B, Preferred Stock
Common Stock
Balance, shares at Dec. 31, 2024                           25,615,000
Balance, amount at Dec. 31, 2024 $ (287,989)       $ 0 $ 1,709,645 $ (2,000,196)       $ 0     $ 2,562
Beneficial conversion feature of note discount 376,700 $ 0 $ 0 $ 0 0 376,700 0       0     0
Net Loss (493,852) 0 0 0 0   (493,852)       0     0
Balance, amount at Mar. 31, 2025 (405,141) 0 0 0 0 2,086,345 (2,494,048)       0     $ 2,562
Balance, shares at Mar. 31, 2025                           25,615,000
Balance, shares at Dec. 31, 2024                           25,615,000
Balance, amount at Dec. 31, 2024 (287,989)       0 1,709,645 (2,000,196)       0     $ 2,562
Net Loss (1,299,619)                          
Balance, amount at Jun. 30, 2025 15,413,878 $ 2,480 $ 33 $ 12 $ 1,188 15,384,226 (3,299,815)       3,323,192     $ 2,562
Balance, shares at Jun. 30, 2025   24,805,000 329,288 115,602 11,876,557                 25,615,000
Balance, shares at Mar. 31, 2025                           25,615,000
Balance, amount at Mar. 31, 2025 (405,141) $ 0 $ 0 $ 0 $ 0 2,086,345 (2,494,048)       0     $ 2,562
Beneficial conversion feature of note discount 115,000 0 0 0 0 115,000 0       0     0
Net Loss (805,767) $ 0 $ 0 $ 0 $ 0 0 (805,767)       0     0
Shares issued for debt conversion, shares   24,805,000 329,288 115,602 11,876,557                  
Shares issued for debt conversion, amount 12,125,928 $ 2,480 $ 33 $ 12 $ 1,188 12,122,215 0       0     0
Employee stock compensation 70,051 0 0 0 0 70,051 0       0     0
Class B Common Stock issuable for earned Contingent Equity Consideration 3,323,192 0 0 0 0 0 0       3,323,192     0
Fair value of warrants issued as deferred offering cost 990,614 0 0 0 0 990,614 0       0     0
Balance, amount at Jun. 30, 2025 15,413,878 $ 2,480 $ 33 $ 12 $ 1,188 15,384,226 (3,299,815)       $ 3,323,192     $ 2,562
Balance, shares at Jun. 30, 2025   24,805,000 329,288 115,602 11,876,557                 25,615,000
Balance, shares at Dec. 31, 2025   24,560,000 329,288 115,502 15,374,651       892,441       4 27,043,000
Balance, amount at Dec. 31, 2025 10,441,377 $ 2,456 $ 33 $ 12 $ 1,537 20,222,861 (9,791,120) $ 0 $ 89 $ 2,805   $ 0 $ 0 $ 2,704
Net Loss (1,051,493) 0 0 0 0 0 (1,051,493) 0 $ 0 0   0 0 0
Shares issued for debt conversion, shares                 148,372          
Shares issued for debt conversion, amount 63,800 0 0 0 0 63,785 0 0 $ 15 0   0 0 0
Employee stock compensation 396,021 0 0 0 0 396,021 0 0 0 0   0 0 $ 0
Sales of common stock pursuant to equity purchase agreement, shares                           82,374
Sales of common stock pursuant to equity purchase agreement, amount 64,669 0 0 0 0 64,661 0 0 $ 0 0   0 0 $ 8
Sales of Series D.1 Preferred Stock, shares                 232,558          
Sales of Series D.1 Preferred Stock, amount 100,000 $ 0 0 0 0 99,977 0 0 $ 23 0   0 0 $ 0
Conversion of Series A Preferred Stock to Common Stock, shares   (13,366)                       40,100
Conversion of Series A Preferred Stock to Common Stock, amount 0 $ (1) 0 0 0 (3) 0 0 0 0   0 0 $ 4
Conversion of Common Stock to Series A Preferred Stock, shares   105,000                       (315,000)
Conversion of Common Stock to Series A Preferred Stock, amount 0 $ 10 $ 0 0 0 21 0 0 0 0   0 0 $ (31)
Conversion of Series C Preferred Stock to Common Stock, shares     (67)                     100
Conversion of Series C Preferred Stock to Common Stock, amount 0 0 $ 0 $ 0 0 0 0 0 0 0   0 0 $ 0
Conversion of Series D Preferred Stock to Common Stock, shares       (100)                   100
Conversion of Series D Preferred Stock to Common Stock, amount 0 0 0 $ 0 0 0 0 0 0 0   0 0 $ 0
Cash received for Series E Preferred Stock to be issued 110,000 0 0 0 0 0 0 $ 0 0 110,000   0 0 0
Shares issued to consultants, shares               1,667            
Shares issued to consultants, amount 3,246 0 0 0 0 3,246 0 $ 0 0 0   0 0 1
Balance, amount at Mar. 31, 2026 10,127,620 $ 2,465 $ 33 $ 12 $ 1,537 20,850,569 (10,842,613) $ 0 $ 127 112,805   0 $ 0 $ 2,685
Balance, shares at Mar. 31, 2026   24,651,634 329,221 115,402 15,374,651     1,667 1,273,371       4 26,850,674
Balance, shares at Dec. 31, 2025   24,560,000 329,288 115,502 15,374,651       892,441       4 27,043,000
Balance, amount at Dec. 31, 2025 10,441,377 $ 2,456 $ 33 $ 12 $ 1,537 20,222,861 (9,791,120) $ 0 $ 89 2,805   0 $ 0 $ 2,704
Net Loss (3,230,842)                          
Balance, amount at Jun. 30, 2026 8,821,856 $ 2,414 $ 33 $ 12 $ 1,537 21,833,906 (13,021,962) $ 20 $ 127 2,805   $ 32 $ 0 $ 2,932
Balance, shares at Jun. 30, 2026   24,141,252 329,221 115,502 15,374,651     201,667 1,273,271     323,530 4 29,313,869
Balance, shares at Mar. 31, 2026   24,651,634 329,221 115,402 15,374,651     1,667 1,273,371       4 26,850,674
Balance, amount at Mar. 31, 2026 10,127,620 $ 2,465 $ 33 $ 12 $ 1,537 20,850,569 (10,842,613) $ 0 $ 127 112,805   $ 0 $ 0 $ 2,685
Net Loss (2,179,349) 0 0 0 0 0 (2,179,349) 0 0 0   0 0 $ 0
Shares issued for debt conversion, shares                           406,150
Shares issued for debt conversion, amount 78,311 0 0 0 0 78,270 0 0 0 0   0 0 $ 41
Employee stock compensation 398,847 0 0 0 0 398,847 0 0 0 0   0 0 $ 0
Sales of common stock pursuant to equity purchase agreement, shares                           104,708
Sales of common stock pursuant to equity purchase agreement, amount 24,628 $ 0 0 0 0 24,618 0 0 0 0   0 0 $ 10
Conversion of Series A Preferred Stock to Common Stock, shares   (510,382)                       1,531,146
Conversion of Series A Preferred Stock to Common Stock, amount 0 $ (51) 0 0 0 (102) 0 0 0 0   0 0 $ 153
Shares issued to consultants, shares                           500,000
Shares issued to consultants, amount 160,050 0 0 $ 0 0 160,000 0   $ 0 0   0 0 $ 50
Reclassification of share from Series D.1 to Series D, shares       100         (100)          
Reclassification of share from Series D.1 to Series D, amount 0 0 0 $ 0 0 0 0 0 $ 0 0   0 0 $ 0
Sales of common stock pursuant to private placements, shares                           476,191
Sales of common stock pursuant to private placements, amount 49,004 0 0 0 0 48,956 0 0 0 0   0 0 $ 48
Warrants attached to common stock sales 50,996 0 0 0 0 50,996 0 0 0 0   $ 0 0 0
Issuance of equity issuable, shares                       323,530    
Issuance of equity issuable, amount 0 0 0 0 0 $ 109,968 0 $ 0 0 (110,000)   $ 32 0 $ 0
Conversion of common stock to class A.1 preferred stock, shares           40   200,000           (600,000)
Conversion of common stock to class A.1 preferred stock, amount   0 0 0 0     $ 20 0 0   0 0 $ (60)
Shares attached to convertible note, shares                           45,000
Shares attached to convertible note, amount 12,976 0 0 0 0 $ 12,971 0 0 0 0   0 0 $ 5
Warrants attached to convertible note 98,773 0 0 0 0 98,773 0 0 0 0   0 0 0
Balance, amount at Jun. 30, 2026 $ 8,821,856 $ 2,414 $ 33 $ 12 $ 1,537 $ 21,833,906 $ (13,021,962) $ 20 $ 127 $ 2,805   $ 32 $ 0 $ 2,932
Balance, shares at Jun. 30, 2026   24,141,252 329,221 115,502 15,374,651     201,667 1,273,271     323,530 4 29,313,869